Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value

M&A

XenoTherapeutics Inc. and Xeno Acquisition Corp, a non-profit biotechnology company, on Friday agreed to acquire Repare Therapeutics Inc. (NASDAQ:RPTX).

Repare shareholders will receive a cash payment per Common Share, determined based on Repare’s cash balance at closing of the transaction, after deducting certain transaction costs and the aggregate amount of outstanding liabilities.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.